Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
Lu Lu(Fudan University), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Carol Ho-Yan Fong(Chinese University of Hong Kong), Lin‐Lei Chen(Queen Mary Hospital), Hoi‐Wah Tsoi(University of Hong Kong), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Syed Muhammad Abdullah(University of Hong Kong), Wai-Shing Leung(Hospital Authority), Thomas Shiu‐Hong Chik, Daphne Pui-Ling Lau, Charlotte Yee-Ki Choi(University of Hong Kong), Jian‐Piao Cai(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Chris Yau-Chung Choi, Xiaojuan Zhang(Jiangnan University), Kwok‐Hung Chan(University of Hong Kong), Brian Pui-Chun Chan(University of Hong Kong), Jacky Man‐Chun Chan(University of Hong Kong - Shenzhen Hospital), Ruiqi Zhang(University of Hong Kong), Owen Tak‐Yin Tsang(Hospital Authority), Anthony Raymond Tam(University of Hong Kong)
Cited by 30
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k